APA (7th ed.) Citation

Behrendt, C., Rother, U., Rümenapf, G., Uhl, C., Görtz, H., & Böckler, D. (2020). Randomized controlled trials and real-world evidence for market access and surveillance of high-risk products: The example of paclitaxel. Gefässchirurgie, 25, . https://doi.org/10.1007/s00772-020-00726-0

Chicago Style (17th ed.) Citation

Behrendt, Christian-Alexander, Ulrich Rother, Gerhard Rümenapf, Christian Uhl, Hartmut Görtz, and Dittmar Böckler. "Randomized Controlled Trials and Real-world Evidence for Market Access and Surveillance of High-risk Products: The Example of Paclitaxel." Gefässchirurgie 25 (2020). https://doi.org/10.1007/s00772-020-00726-0.

MLA (9th ed.) Citation

Behrendt, Christian-Alexander, et al. "Randomized Controlled Trials and Real-world Evidence for Market Access and Surveillance of High-risk Products: The Example of Paclitaxel." Gefässchirurgie, vol. 25, 2020, https://doi.org/10.1007/s00772-020-00726-0.